Programmable immunotherapy in precision oncology: integrating oncolytic viruses and neoantigen vaccines
Oncolytic viruses and therapeutic cancer vaccines are two immunotherapy platforms whose trajectories increasingly intersect. Both aim not only to destroy malignant cells